Nonoperative Management of Venous Leg Ulcers: Evolving Role of Skin Substitutes

Vascular and Endovascular Surgery

Volumn 33, Issue 2, 1999, Pages 197-210

  Moneta, Gregory L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECAPLERMIN; CYTOKINE; FIBRINOLYTIC AGENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; PENTOXIFYLLINE; PLACEBO; PLATELET DERIVED WOUND HEALING FACTOR; PROCUREN; PROSTAGLANDIN DERIVATIVE; RECOMBINANT PLATELET DERIVED GROWTH FACTOR BB; SCAVENGER; UNCLASSIFIED DRUG; ZINC;

ARTICLE; ARTIFICIAL SKIN; BIOTECHNOLOGY; CLINICAL TRIAL; COMPRESSION THERAPY; CONSERVATIVE TREATMENT; HUMAN; LEG ULCER; TOPICAL DRUG ADMINISTRATION; ULCER HEALING;

EID: 0033043853     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/153857449903300217     Document Type: Article

References (82)

1. Brand FN, Dannenberg AL, Abbott RD, et al: The epidemiology of varicose veins: The Framingham Study. Am J Prev Med. 4:96-101, 1988.
2. Coon WW, Willis PW III, Keller JB: Venous thromboembolism and other venous disease in the Tecumseh Community Health Study. Circulation. 48:839-846, 1973.
3. Angle N, Bergan JJ: Chronic venous ulcer. Br Med J. 314:1019-1023, 1997.
4. Phillips T, Stanton B, Provan A, et al: A study of the impact of leg ulcers on quality of life: Financial, social, and psychologic implications. J Am Acad Dermatol. 31:49-53, 1994.
5. Phillips TJ, Dover JS: Leg ulcers. J Am Acad Dermatol. 25:965-987, 1991.
6. Fitzpatrick JE: Stasis ulcers: Update on a common geriatric problem. Geriatrics. 44:19-31, 1989.
7. Gourdin FW, Smith JG Jr: Etiology of venous ulceration. South Med J. 86:1142-1146, 1993.
8. Black SB: Venous stasis ulcers: A review. Ostomy Wound Manage. 41:20-22, 24-26, 28-30, 32-32, 1995.
9. Falanga V: Venous ulceration. Wounds. 8:102-108, 1996.
10. Falanga V, Eaglstein WH: The “trap” hypothesis of venous ulceration. Lancet. 341:1006-1008, 1993.
11. Kistner RL, Eklof B, Masuda EM: Diagnosis of chronic venous disease of the lower extremities: The “CEAP” classification. Mayo Clin Proc. 71:338-345, 1996.
12. McGuckin M, Stineman M, Goin J, et al: Draft guideline: Diagnosis and treatment of venous leg ulcers. Ostomy Wound Manage. 42:48-78, 1996.
13. McGuckin M, Stineman M, Goin J, et al: Draft guideline: Diagnosis and treatment of venous leg ulcers. Ostomy Wound Manage. 42:100-114, 1996.
14. Sieggreen MY, Cohen IK, Kloth LC, et al: Commentaries on venous leg ulcers diagnostic and treatment draft guideline. Adv Wound Care. 9:18-26, 1996.
15. Korstanje MJ: Venous stasis ulcers: Diagnostic and surgical considerations. Dermatol Surg. 21:635-640, 1995.
16. Margolis DJ, Cohen JH: Management of chronic venous leg ulcers: A literature-guided approach. Clin Dermatol. 12:19-26, 1994.
17. Cairns BA, deSerres S, Peterson HD, et al: Skin replacements: The biotechnological quest for optimal wound closure. Arch Surg. 128:1246-1252, 1993.
18. Kannon GA, Garrett AB: Moist wound healing with occlusive dressings: A clinical review. Dermatol Surg. 21:583-590, 1995.
19. Cooper ML, Spielvogel RL: Artificial skin for wound healing. Clin Dermatol. 12:183-191, 1994.
20. Wainwright D, Madden M, Luterman A, et al: Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns. J Burn Care Rehabil. 17:124-136, 1996.
21. Dougherty WR, Chalabian JR: Skin substitutes. West J Med. 162:540-541, 1995.
22. Falanga V, Margolis D, Alvarez O, et al: Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch Dermatol. 134:293-300, 1988.
23. Eaglstein WH, Iriondo M, Laszlo K: A composite skin substitute (Graftskin) for surgical wounds: A clinical experience. Dermatol Surg. 21:839-843, 1995.
24. Fletcher A, Cullum N, Sheldon TA: A systematic review of compression treatment for venous leg ulcers. Br Med J. 315:576-580, 1997.
25. Stewart AJ, Leaper DJ: Treatment of chronic leg ulcers in the community: A comparative trial of Scherisorb and Iodosorb. Phlebology. 2:115-121, 1987.
26. Ormiston MC, Seymour MTJ, Venn GE, et al: Controlled trial of Iodosorb in chronic venous ulcers. Br Med J. 291:308-310, 1985.
27. Ryan TJ, Given HF, Murphy JJ, et al: The use of a new occlusive dressing in the management of venous stasis ulceration. In: An Environment for Healing: The Role of Occlusion; no. 88, ed. by Ryan TJ. London: Royal Society of Medicine, 1984, pp 99-103.
28. Eriksson G: Comparative study of hydrocolloid dressing and double layer bandage in treatment of venous stasis ulceration. In: An Environment for Healing: The Role of Occlusion; no. 88, ed. by Ryan TJ. London: Royal Society of Medicine, 1985, pp 111-113.
29. Nix WM: The Unna boot: A therapeutic modality by a dermatologic polymath. Am J Dermatopathol. 7:259-260, 1985.
30. Burton CS III: Treatment of leg ulcers. Dermatol Clin. 11:315-323, 1993.
31. Mayberry JC, Moneta GL, Taylor LM Jr, et al: Fifteenyear results of ambulatory compression therapy for chronic venous ulcers. Surgery. 109:575-581, 1991.
32. Wright AD: The treatment of indolent ulcer of the leg. Lancet. 1:457-460, 1931.
33. Anning ST: Leg ulcers-the results of treatment. Angiology. 7:505-517, 1956.
34. Kitahama A, Elliott LF, Kerstein MD, et al: Leg ulcer: Conservative management or surgical treatment? JAMA. 247:197-199, 1982.
35. Vernick SH, Shapiro D, Shaw FD: Legging orthosis for venous and lymphatic insufficiency. Arch Phys Med Rehabil. 68:459-461, 1987.
36. Smith PC, Sarin S, Hasty J, et al: Sequential gradient pneumatic compression enhances venous ulcer healing: A randomized trial. Surgery. 108:871-875, 1990.
37. Browse NL, Burnand KG: The cause of venous ulceration. Lancet. 2:243-245, 1982.
38. Colgan M-P, Dormandy JA, Jones PW, et al: Oxpentifylline treatment of venous ulcers of the leg. Br Med J. 300:972-975, 1990.
39. Eklund AE, Eriksson G, Olsson AG: A controlled study showing significant short term effect of prostaglandin El in healing of ischemic ulcers of the lower limb in man. Prostaglandins Leukot Med. 8:265-271, 1982.
40. Salim AS: The role of oxygen-derived free radicals in the management of venous (varicose) ulceration: A new approach. World J Surg. 15:264-269, 1991.
41. Hachen HJ, Lorenz P: Double-blind clinical and plethysmographic study of calcium dobesilate in patients with peripheral microvascular disorders. Angiology. 33:480-488, 1982.
42. Greaves M, Boyde TRC: Plasma-zinc concentrations in patients with psoriasis, other dermatoses, and venous leg ulceration. Lancet. 2:1019-1020, 1967.
43. Ganio C, Tenewitz FE, Wilson RC, et al: The treatment of chronic nonhealing wounds using autologous platelet-derived growth factors. J Foot Ankle Surg. 32:263-268, 1993.
44. Bishop JB, Phillips LG, Mustoe TA, et al: A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers. J Vasc Surg. 16:251-257, 1992.
45. Roelens P: Double-blind placebo-controlled study with topical 2% ketanserin ointment in the treatment of venous ulcers. Dermatologica. 178:98-102, 1989.
46. Wilkins LM, Watson SR, Prosky SJ, et al: Development of a bilayered living skin construct for clinical applications. Biotechnol Bioeng. 43:747-756, 1994.
47. McHugh TP, Robson MC, Heggers JP, et al: Therapeutic efficacy of Biobrane in partialand full-thickness thermal injury. Surgery. 100:661-664, 1986.
48. Moneta GL, Nehler MR, Chitwood RW, et al: The natural history, pathophysiology, and nonoperative treatment of chronic venous insufficiency. In: Vascular Surgery, 4th ed. ed. by Rutherford RB. Philadelphia: W. B. Saunders, 1995, pp 1837-1850.
49. Douglas WS, Simpson NB: Guidelines for the management of chronic venous leg ulceration: Report of a multidisciplinary workshop. Br J Dermatol. 132:446-452, 1995.
50. Stemmer R, Marescaux J, Furderer C: Compression therapy of the lower extremities particularly with compression stockings [in German]. Hautarzt. 31:355-365, 1980.
51. Hendricks WM, Swallow RT: Management of stasis leg ulcers with Unna's boots versus elastic support stockings. J Am Acad Dermatol. 12:90-98, 1985.
52. Sigel B, Edelstein AL, Savitch L, et al: Type of compression for reducing venous stasis: A study of lower extremities during inactive recumbency. Arch Surg. 110:171-175, 1975.
53. Nehler MR, Moneta GL, Porter JM: The lower extremity venous system. Part II: The pathophysiology of chronic venous insufficiency. Perspect Vasc Surg. 5:81-97, 1992.
54. Partsch H: Compression therapy of the legs: A review. J Dermatol Surg Oncol. 17:799-805, 1991.
55. Phillips TJ: New skin for old: Developments in biological skin substitutes [editorial; comment]. Arch Dermatol. 134:344-349, 1998.
56. Richmand DM, O'Donnell TF Jr, Zelikovski A: Sequential pneumatic compression for lymphedema: A controlled trial. Arch Surg. 120:1116-1119, 1985.
57. Falanga V, Eaglstein WH: Wound healing: Practical aspects. Prog Dermatol. 22:1-10, 1988.
58. Pekanmaki K, Kolari PJ, Kiistala U: Intermittent pneumatic compression treatment for postthrombotic leg ulcers. Clin Exp Dermatol. 12:350-353, 1987.
59. Sullivan GW, Carper HT, Novick WJ Jr, et al: Inhibition of the inflammatory action of interleukin1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immun. 56:1722-1729, 1988.
60. Falanga V: High dose pentoxifylline for venous ulcers. In: The 10th Annual Symposium on Advanced Wound Care & 7th Annual Medical Research Forum on Wound Repair. April 12-16, 1997; New Orleans, LA.
61. Rhodes P: An Outline History of Medicine. London: Butterworths, 1985, p 1-1.
62. Gilchrist B: Infection and culturing. In: Chronic Wound Care: A Clinical Source Book for Healthcare Professionals, 2nd ed. ed. by Krasner D, Kane D. Wayne, PA: Health Management Publications, Inc. 1997, pp 109-114.
63. Falanga V, Eaglstein WH: Management of venous ulcers. Am Fam Physician. 33:274-281, 1986.
64. Lineaweaver W, Howard R, Soucy D, et al: Topical antimicrobial toxicity. Arch Surg. 120:267-270, 1985.
65. Bolton L, Oleniacz W, Constantine B, et al: Repair and antibacterial effects of topical antiseptic agents in vivo. In: Models in Dermatology. Vol. 2: Dermatopharmacology and Toxicology, ed. by Maibach HI, Lowe NJ. Basel: Karger, 1985, pp 145-158.
66. Martin P, Hopkinson-Woolley J, McCluskey J: Growth factors and cutaneous wound repair. Prog Growth Factor Res. 4:25-44, 1992.
67. Braunstein S, Kaplan G, Gottlieb AB, et al: GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo. J Invest Dermatol. 103:601-604, 1994.
68. Knighton DR, Fiegel VD, Doucette MM, et al: The use of topically applied platelet growth factors in chronic nonhealing wounds: A review. Wounds. 1:71-78, 1998.
69. Kaplan G, Walsh G, Guido LS, et al: Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J Exp Med. 175:1717-1728, 1992.
70. Steed DL, and the Diabetic Ulcer Study Group: Clinical evaluation of recombinant human plateletderived growth factor for the treatment of lower extremity diabetic ulcers. J Vasc Surg. 21:71-81, 1995.
71. Phillips LG, Abdullah KM, Geldner PD, et al: Application of basic fibroblast growth factor may reverse diabetic wound healing impairment. Ann Plast Surg. 31:331-334, 1993.
72. Falanga V, Eaglstein WH, Bucalo B, et al: Topical use of human recombinant epidermal growth factor (hEGF) in venous ulcers. J Dermatol Surg Oncol. 18:604-606, 1992.
73. Phillips TJ: Biologic skin substitutes. J Dermatol Surg Oncol. 19:794-800, 1993.
74. Gentzkow GD, Iwasaki SD, Hershon KS, et al: Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care. 19:350-354, 1996.
75. Gentzkow GD: Dermagraft®, tissue-engineered human dermal replacement, in the management of diabetic foot ulcers. In: The 10th Annual Symposium on Advanced Wound Care & 7th Annual Medical Research Forum on Wound Repair. April 12-16, 1997; New Orleans, LA.
76. Pollak RA, Edington H, Jensen JL, et al: A human dermal replacement for the treatment of diabetic foot ulcers. Wounds. 9:175-183, 1997.
77. Heimbach D, Luterman A, Burke J, et al: Artificial dermis for major burns: A multicenter randomized clinical trial. Ann Surg. 208:313-320, 1988.
78. Parenteau NL, Nolte CM, Bilbo P, et al: Epidermis generated in vitro: Practical considerations and applications. J Cell Biochem. 45:245-251, 1991.
79. Falanga V: Growth factors and chronic wounds: The need to understand the microenvironment. J Dermatol. 19:667-672, 1992.
80. Sabolinski ML, Alvarez O, Auletta M, et al: Cultured skin as a ‘smart material’ for healing wounds: Experience in venous ulcers. Biomaterials. 17:311-320, 1996.
81. Hasan A, Murata H, Falabella A, et al: Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-3 1. J Dermatol Sci. 16:59-66, 1997.
82. Tallman P, Muscare E, Carson P, et al: Initial rate of healing predicts complete healing of venous ulcers. Arch Dermatol. 133:1231-1234, 1997.